Monoterpenes in breast cancer chemoprevention

Breast Cancer Research and Treatment

Volumn 46, Issue 2-3, 1997, Pages 191-197

  Crowell, Pamela L ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Apoptosis; d Limonene; Perillyl alcohol; Rat

Indexed keywords

ALCOHOL; CARCINOGEN; CARVEOL; LIMONENE; PERILLYL ALCOHOL; PROTEIN; SOBREROL; TERPENE; UNCLASSIFIED DRUG; UROTERPENOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CELL DIFFERENTIATION; CELL GROWTH; CHEMOPROPHYLAXIS; CITRUS FRUIT; DETOXIFICATION; DIETARY INTAKE; FEMALE; ISOPRENYLATION; MOUSE; NONHUMAN; PANCREAS TUMOR; PRIORITY JOURNAL; RAT; REVIEW; TUMOR CELL;

ANIMALS; ANTICARCINOGENIC AGENTS; CYCLOHEXENES; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MONOTERPENES; RATS; TERPENES;

EID: 0031446103     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005939806591     Document Type: Review

References (54)

1. McGarvey DJ, Croteau R: Terpenoid metabolism. Plant Cell 7:1015-1026, 1995
2. 3H]-geranyl pyrophosphate by soluble enzymes from Citrus limonum. Arch Biochem Biophys 180:318-327, 1977
3. Kjonaas R, Croteau R: Demonstration that limonene is the first cyclic intermediate in the biosynthesis of oxygenated p-menthane monoterpenes in Mentha piperita and other Mentha species. Arch Biochem Biophys 220:79-89, 1983
4. Alonso WR, Rajaonarivony JIM, Gershenzon J, Croteau R: Purification of 4S-limonene synthase, a monoterpene cyclase from the glandular trichomes of peppermint (Mentha x piperita) and spearmint (Mentha spicata). J Biol Chem 267:7582-7587, 1992
5. Karp F, Mihaliak CA, Harris JL, Croteau R: Monoterpene biosynthesis: specificity of the hydroxylations of (-)-limonene by enzyme preparations from peppermint (Mentha piperita), spearmint (Mentha spicata), and perilla (Perilla frutescens) leaves. Arch Biochem Biophys 276:219-226, 1990
6. National Toxicology Program: Toxicology and carcinogenesis studies of d-limonene in F-344/N rats and B6C3F1 mice (gavage study), NTP TR 347. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1990
7. Welsch C: Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 45: 3415-3443, 1985
8. Elegbede JA, Elson CE, Qureshi A, Tanner MA, Gould MN: Inhibition of DMBA-induced mammary cancer by the monoterpene d-limonene. Carcinogenesis 5:661-665, 1984
9. Maltzman TH, Hurt LM, Elson CE, Tanner MA, Gould MN: The prevention of nitrosomethylurea-induced mammary tumors by d-limonene and orange oil. Carcinogenesis 10:781-785, 1989
10. Jefcoate CR: Integration of xenobiotic metabolism and carcinogen activation and detoxication. In: Caldwell J, Jacoby WB (eds) Biological Basis of Detoxication. Academic Press, New York, 1983
11. Wilson NM, Christou M, Turner CR, Wrighton SA, Jefcoate CR: Binding and metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene by seven purified forms of cytochrome P-450. Carcinogenesis 5:1475-1483, 1984
12. Christou M, Moore CJ, Gould MN, Jefcoate CR: Induction of mammary cytochromes P-450: an essential first step in the metabolism of 7,12-dimethylbenz[a]anthracene by rat mammary epithelial cells. Carcinogenesis 8:73-80, 1987
13. Elson CE, Maltzman TH, Boston JL, Tanner MA, Gould MN: Anti-carcinogenic activity of d-limonene during the initiation and promotion-progression stages of DMBA-induced rat mammary carcinogenesis. Carcinogenesis 9:331-332, 1988
14. Crowell PL, Kennan WS, Haag JD, Ahmad S, Vedejs E, Gould MN: Chemoprevention of mammary carcinogenesis by hydroxylated derivatives of d-limonene. Carcinogenesis 13:1261-1264, 1992
15. Russin WA, Hoesly JD, Elson CE, Tanner MA, Gould MN: Inhibition of rat mammary carcinogenesis by monoterpenoids. Carcinogenesis 10:2161-2165, 1989
16. Wattenberg LW: Inhibition of neoplasia by minor dietary constituents. Cancer Res 43:2448s-2453s, 1983
17. Wattenberg LW: Inhibition of carcinogenesis by minor dietary constituents. Cancer Res 52:2085s-2091s, 1992
18. Ariyoshi T, Arakaki M, Ideguchi K, Ishizuka Y, Noda K: Studies on the metabolism of d-limonene (p-mentha-1,8-diene). III. Effects of d-limonene on the lipids and drug-metabolizing enzymes in rat livers. Xenobiotica 5:33-38, 1975
19. Austin CA, Shephard EA, Pike SF, Rabin BR, Phillips IR: The effect of terpenoid compounds on cytochrome P-450 levels in rat liver. Biochem Pharmacol 37:2223-2229, 1988
20. Maltzman TH, Christou M, Gould MN, Jefcoate CR: Effects of monoterpenoids on in vivo DMBA-DNA adduct formation and on phase I hepatic metabolizing enzymes. Carcinogenesis 12:2081-2090, 1991
21. Elegbede JA, Maltzman TH, Elson CE, Gould MN: Effects of anticarcinogenic monoterpenes on phase II hepatic metabolizing enzymes. Carcinogenesis 14: 1221-1225, 1993
22. Elegbede JA, Elson CE, Tanner MA, Qureshi A, Gould MN: Regression of rat primary mammary tumors following dietary d-limonene. J Natl Cancer Inst 76: 323-325, 1986
23. Haag JD, Lindstrom MJ, Gould MN: Limonene-induced regression of mammary carcinomas. Cancer Res 52:4021-4026, 1992
24. Haag JD, Gould MN: Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene. Cancer Chemother Pharmacol 34:477-483, 1994
25. Stark MJ, Burke YD, McKinzie JH, Ayoubi AS, Crowell PL: Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol. Cancer Lett 96: 15-21, 1995
26. McNamee D: Limonene trial in cancer. Lancet 342: 801, 1993
27. Chander SK, Lansdown AGB, Luqmani YA, Gomm JJ, Coope RC, Gould MN, Coombes RC: Effectiveness of combined limonene and 4-hydroxyandrostenedione in the treatment of NMU-induced rat mammary tumors. Br J Cancer 69:879-882, 1994
28. Morse MA, Stoner GD: Cancer chemoprevention: principles and prospects. Carcinogenesis 14:1737-1746, 1993
29. Shi W, Gould MN: Induction of differentiation in neuro-2A cells by the monoterpene perillyl alcohol. Cancer Lett 95:1-6, 1995
30. Jirtle RL, Haag JD, Ariazi E, Gould MN: Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor β1 levels during monoterpene-induced regression of mammary tumors. Cancer Res 53:3849-3853, 1993
31. Ariazi E, Gould MN: Identifying differential gene expression in monoterpene-treated mammary carcinomas using subtractive display. J Biol Chem 271: 29286-29294, 1996
32. Mills JJ, Chari RS, Boyer IJ, Gould MN, Jirtle RL: Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res 55:979-983, 1995
33. Reddy BS, Wang CX, Samaha H, Lubet R, Steele VE, Kelloff GJ, Rao CV: Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. Cancer Res 57:420-425, 1997
34. Crowell PL, Ayoubi AS, Burke YD: Antitumorigenic effects of d-limonene and perillyl alcohol against pancreatic and breast cancer. Adv Exper Med Biol 401:131-136, 1996
35. Elson CE: Suppression of mevalonate pathway activities by dietary isoprenoids: protective roles in cancer and cardiovascular disease. J Nutr 125:1666S-1672S, 1995
36. Clegg RJ, Middleton B, Bell D, White DA: Inhibition of hepatic cholesterol synthesis and S-3-hydroxy-3-methylglutaryl-CoA reductase by mono and bicyclic monoterpenes administered in vivo. Biochemical Pharmacol 29:2125-2127, 1980
37. Clegg RJ, Middleton B, Bell D, White DA: The mechanism of cyclic monoterpene inhibition of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase in vivo in the rat. J Biol Chem 257:2294-2299, 1982
38. Qureshi AA, Mangels WR, Din ZZ, Elson CE: Inhibition of hepatic mevalonate biosynthesis by the monoterpene, d-limonene. J Agric Food Chem 36:1220-1224, 1988
39. Ren Z, Gould MN: Inhibition of ubiquinone and cholesterol synthesis by the monoterpene perillyl alcohol. Cancer Lett 76:185-190, 1994
40. Crowell PL, Chang RR, Ren Z, Elson CE, Gould MN: Selective inhibition of isoprenylation of 21-26 kDa proteins by the anticarcinogen d-limonene and its metabolites. J Biol Chem 266:17679-17685, 1991
41. Crowell PL, Lin S, Vedejs E, Gould MN: Identification of metabolites of the antitumor agent d-limonene capable of inhibiting protein isoprenylation and cell growth. Cancer Chemother Pharmacol 31:205-212, 1992
42. Crowell PL, Ren Z, Lin S, Vedejs E, Gould MN: Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. Biochemical Pharmacol 47:1405-1415, 1994
43. Gelb MH, Tamanoi F, Yokoyama K, Ghomashchi F, Esson K, Gould MN: The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol. Cancer Lett 91:169-175, 1995
44. Kawata S, Hagase T, Yamasaki E, Ishiguro H, Matsuzawa Y: Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2). Br J Cancer 69:1015-1020, 1994
45. Schulz S, Buhling F, Ansorge S: Prenylated proteins and lymphocyte proliferation: inhibition by d-limonene and related monoterpenes. Eur J Immunol 24:301-307, 1994
46. Zhang FL, Casey PJ: Protein prenylation: molecular mechanisms and functional consequences. Ann Rev Biochem 65:241-269, 1996
47. Goldstein JL, Brown MS: Regulation of the mevalonate pathway. Nature 343:425-430, 1990
48. Phillips LR, Malspeis L, Supko JG: Pharmacokinetics of active drug metabolites after oral administration of perillyl alcohol, an investigational antineoplastic agent, to the dog. Drug Metab Disposition 23:676-680, 1995
49. CAAX protein tyrosine phosphatases. Cancer Lett 110:49-55, 1996
50. Kato K, Cox AD, Hisaka MM, Graham SM, Buss JE, Der CJ: Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity. Proc Natl Acad Sci USA 89: 6403-6407, 1992
51. Ruch RJ, Sigler K: Growth inhibition of rat liver epithelial tumor cells by monoterpenes does not involve Ras plasma membrane association. Carcinogenesis 15: 787-789, 1994
52. Gould MN, Moore CJ, Zhang R, Wang B, Kennan WS, Haag JD: Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras. Cancer Res 54:3540-3543, 1994
53. Graham SM, Cox AD, Drivas G, Rush MG, D'Eustachio P, Der CJ: Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation. Mol Cell Biol 14:4108-4115, 1994
54. Perona R, Esteve P, Jimenez B, Ballestero RP, Ramon y Cajal S, Lacal JC: Tumorigenic activity of rho genes from Aplysia californica. Oncogene 8:1285-1292, 1993